Insights On Partnering

  1. Canadian CTA Frequently Asked Questions 2/20/2024

    This FAQ list offers clarity on pivotal aspects of your drug development journey, ensuring studies in Canada pave the way for U.S. FDA and EMA submissions.

  2. 2023 Site Payments And Budgeting Market Trends Survey 3/7/2024

    Explore the findings from this survey of the global clinical trials market, shedding light on processes, challenges, and preferences associated with global site payments, and more.

  3. Faster Trial Planning and Site Selection 4/15/2025

    Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.

  4. Cell And Gene Therapy Development – 3 Key Challenges In 2023 10/29/2023

    Considering the current landscape, here are three critical factors for cell and gene therapy developers to overcome obstacles and advance development.

  5. Global Start-Up For Multinational Geographic Atrophy Trial 6/26/2025

    This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.

  6. The Greatest Impact Of Tax In Clinical Research 5/15/2024

    In a recent Site Survey, Greenphire collected site perspectives on taxation in clinical trials and its impact on participants. Here, we review several real-life examples that were shared by survey participants.

  7. Uncovering The Root Cause Of Clinical Trial Troubles 12/10/2024

    Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.

  8. Robust Models For Supporting PV And Medical Information Activity 8/15/2023

    Learn how outsourcing local pharmacovigilance and medical information activities to an established safety organization can provide high-quality expertise and technology that meets demand.

  9. Tailored Solutions For A Global Phase III Neovascular AMD Study 3/17/2025

    How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?

  10. Successful Manufacturing Of Clinical Trial Supply 8/27/2024

    Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.